MeSH term
Frequency | Condition_Probility | Adolescent | 2 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Female | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Humans | 14 | 0.0 |
Infant | 2 | 0.0 |
Male | 2 | 0.0 |
Metalloproteins/genetics/metabolism | 2 | 33.0 |
Polymerase Chain Reaction | 2 | 0.0 |
*Proto-Oncogene Proteins | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Survival Rate | 2 | 0.0 |
*Transcription Factors | 6 | 0.0 |
Cell Line | 3 | 0.0 |
*Helix-Loop-Helix Motifs | 3 | 3.0 |
Animals | 6 | 0.0 |
*Chromosomes, Human, Pair 19 | 2 | 0.0 |
Base Sequence | 6 | 0.0 |
Comparative Study | 4 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Gene Rearrangement | 2 | 0.0 |
Leukemia, T-Cell, Acute/*genetics | 5 | 12.0 |
Prognosis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Mice | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
DNA | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Oncogenes | 2 | 0.0 |